Analysis of gut microbiota in patients with neuromuscular syndromes compared to control-groups
- Conditions
- G70.0G70.8Myasthenia gravisOther specified myoneural disorders
- Registration Number
- DRKS00017134
- Lead Sponsor
- Klinik für Neurologie, Universitätsmedizin Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Diagnosed myasthenia gravis or disorders of the control group; legal age; signed consent
Exclusion Criteria
chronic-inflammatory bowel diseases (i.e. colitis ulcerosa); short bowel syndrome; irritable bowel syndrome; intake of probiotics within the last 3 months; history of bowel resection; intake of antibiotics within the last month; pregnancy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant alteration of gut microbiota of patients with myasthenia gravis compared to control patients (with non-inflammatory neurological diseases or with other autoimmune diseases of the peripheral nervous system).
- Secondary Outcome Measures
Name Time Method Significant alteration of gut microbiota of patients with myasthenia gravis compared to healthy controls